HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeting glucose metabolism in chondrosarcoma cells enhances the sensitivity to doxorubicin through the inhibition of lactate dehydrogenase-A.

Abstract
Chondrosarcoma is a malignant cartilage-forming cancer composed of cells derived from transformed cells that produce cartilage. Conventional chemotherapy and radiotherapy have very limited efficacy in patients with advanced chondrosarcoma. In the present study, we reported a novel therapeutic approach in the treatment of chondrosarcoma cells. We detected that lactate dehydrogenase-A (LDHA) is highly active in chondrosarcoma cells and chondrosarcoma patient samples compared with normal chondrocyte cell lines and primary human chondrocyte. Moreover, chondrosarcoma cells exhibited elevated levels of LDHA expression under doxorubicin treatment. To further explore the mechanisms, we generated doxorubicin-resistant cells from SW1353 chondrosarcoma cell line. Notably, the activity and expression of LDHA are upregulated in doxorubicin-resistant cells. Moreover, our data showed a strong correlation between glucose metabolism and doxorubicin resistance in chondrosarcoma cells; doxorubicin-resistant cells displayed highly activated glucose metabolism and depended more on glucose supply. Finally, we reported a synergistic effect produced by incorporating doxorubicin with glycolysis inhibitors-oxamate in the combined treatment of chondrosarcoma cells in vitro and in vivo. In summary, the present study may aid in the development of new approaches using the combination of chemotherapeutic agents for the treatment of chondrosarcoma patients.
AuthorsGuojun Hua, Yunpeng Liu, Xiangyong Li, Peirong Xu, Yuchun Luo
JournalOncology reports (Oncol Rep) Vol. 31 Issue 6 Pg. 2727-34 (Jun 2014) ISSN: 1791-2431 [Electronic] Greece
PMID24789077 (Publication Type: Journal Article)
Chemical References
  • Isoenzymes
  • Doxorubicin
  • L-Lactate Dehydrogenase
  • Lactate Dehydrogenase 5
  • Glucose
Topics
  • Bone Neoplasms (drug therapy, genetics, pathology)
  • Cell Line, Tumor
  • Chondrosarcoma (drug therapy, genetics, pathology)
  • Doxorubicin (administration & dosage)
  • Drug Resistance, Neoplasm (genetics)
  • Gene Expression Regulation, Neoplastic
  • Glucose (metabolism)
  • Humans
  • Isoenzymes (antagonists & inhibitors, biosynthesis)
  • L-Lactate Dehydrogenase (antagonists & inhibitors, biosynthesis)
  • Lactate Dehydrogenase 5

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: